House committee debates IRA changes that would impact orphan drugs and other areas

US law­mak­ers in the House of Rep­re­sen­ta­tives are look­ing at mul­ti­ple bills that would make changes to the In­fla­tion Re­duc­tion Act, in­clud­ing how Medicare price ne­go­ti­a­tions are im­ple­ment­ed and which drugs are el­i­gi­ble for ex­emp­tions.

In a three-hour hear­ing by the House Com­mit­tee on En­er­gy and Com­merce on Thurs­day, rep­re­sen­ta­tives were par­tic­u­lar­ly fo­cused on the bi­par­ti­san Op­ti­miz­ing Re­search Progress Hope And New (OR­PHAN) Cures Act and Main­tain­ing In­vest­ments in New In­no­va­tion (MI­NI) Act.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.